Description |
tenascin R |
contactin 1 |
Image |
No pdb structure |
|
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- 3-month functional outcome in ischaemic stroke (modified Rankin score) ( 30796134)
- Attention deficit hyperactivity disorder ( 30563984)
- Body mass index ( 26426971)
- Corneal astigmatism ( 29422769)
- Disease progression to choroidal neovascularization form in age-related macular degeneration ( 29346644)
- Liver fibrosis in non-alcoholic fatty acid liver disease ( 31311600)
- Telomere length ( 30185882)
- Tonometry ( 17903302)
|
- Antidepressant treatment resistance (> 2 drugs prescribed) ( 30700811)
- Blood protein levels ( 30072576)
- Body mass index ( 26426971)
- Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging) ( 26252872)
- Dementia and core Alzheimer's disease neuropathologic changes ( 25188341)
- Metabolite levels (X-11787) ( 23934736)
- Motion sickness ( 25628336)
- Parkinson's disease or first degree relation to individual with Parkinson's disease ( 31701892)
- Pneumoconiosis in silica exposure ( 24986923)
- Protein quantitative trait loci ( 18464913)
|
Interacting Genes |
16 interacting genes:
ACAN
BCAN
CCDC146
CNTN1
LGALS14
MAGEB4
NCAN
NCK2
NFASC
NTAQ1
POLR3C
PSMA1
PTPRZ1
SIGLEC1
TRIM54
VCAN
|
14 interacting genes:
CNTN2
FYN
GPR37
L1CAM
MAPK6
NOTCH1
NOTCH2
PPP1CA
PRNP
PTPRB
SCN3A
SCNN1B
TNC
TNR
|
Entrez ID |
7143 |
1272 |
HPRD ID |
03589 |
07189 |
Ensembl ID |
ENSG00000116147
|
ENSG00000018236
|
Uniprot IDs |
A1L306
Q92752
|
A0A024R104
Q12860
|
PDB IDs |
|
2EE2
3S97
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|